drugset / Trial / NCT02183805

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

NCT02183805 ↗

Phase 2 Terminated 6 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.

Timeline

Start
2014-06-17
Primary completion
2020-12-15
Completion
2020-12-15

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty accruing subjects the study accrual was closed”

Drugs

EvaluationDrugModalityDoseRoute
Subject Abraxane Small molecule 800 mg/m2 —
Subject Carboplatin Small molecule 800 mg/m2 —
Subject Cyclophosphamide Other / unclassified 3000 mg/m2 —

Indications